Editorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsored

FDA-approved · 2019

Rybelsus

Generic: Semaglutide (oral) · Manufactured by Novo Nordisk

First oral GLP-1 medication. Lower doses than injectable semaglutide, resulting in less weight loss. Convenient for patients who prefer pills over injections.

Avg weight loss

5-10% of body weight

Monthly price

$936

With insurance

$10-$150/month typical copay

Approved

2019

How it works

Mechanism
GLP-1 receptor agonist
Administration
Daily oral tablet on empty stomach
Doses
3mg, 7mg, 14mg (daily oral tablet)
Approved for
Type 2 diabetes
Self-pay options
Manufacturer savings programs available
Oral version
Yes

Where to get Rybelsus online

The 5 top-rated providers we’ve reviewed that prescribe Semaglutide (oral).